MedPath

The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients

Not Applicable
Completed
Conditions
Anesthesia Recovery Period, Neuromuscular Blockade
Interventions
Registration Number
NCT01890057
Lead Sponsor
Severance Hospital
Brief Summary

To find out the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound rocuronium-induced neuromuscular block in young and elderly adult patients.

Detailed Description

A previous study reported that elderly patients required a longer time to recover from rocuronium induced neuromuscular block compared to younger patients. Therefore, the aim of this study is to find out the dose of sugammadex for rapid recovery from profound neuromuscular block in young and elderly adult patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • 20-40 years or ≥70 years ASA class I-II patients who received surgery less than 2 hours.
Read More
Exclusion Criteria
  • anticipated difficult intubation
  • neuromuscular, hepatic or renal disorders
  • drug allergy
  • body mass index >30 kg/m2 or body mass index <18 kg/m2
  • emergency surgery
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Young adultsSugammadexTo find out the the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block : Dixon's up-and-down method
Elderly adultsSugammadexTo find out the the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block : Dixon's up-and-down method
Primary Outcome Measures
NameTimeMethod
The dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block2 hour
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath